 The FDA has approved iCAD Incs NASDAQ: ICAD ProFound AI Version 3.0 for Digital Breast Tomosynthesis also known as 3D mammography used to improve the ability to detect early breast cancers. Compared to previous versions of the software, the ProFound AI 3.0 algorithm offers up to a 10 improvement in specificity performance and a 1 improvement in sensitivity. 